Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Marixino 10mg tablets
0411000G0BDAAAA
|
Marixino | Memantine hydrochloride | Central Nervous System | 2 |
|
Melatonin 4mg capsules
0401010ADAAAUAU
|
Melatonin | Melatonin | Central Nervous System | 2 |
|
Melatonin 8mg capsules
0401010ADAABJBJ
|
Melatonin | Melatonin | Central Nervous System | 2 |
|
Meprobamate 400mg tablets
0401020R0AAABAB
|
Meprobamate | Meprobamate | Central Nervous System | 2 |
|
Meptazinol 100mg/1ml solution for injection ampoules
0407020L0AAAAAA
|
Meptazinol hydrochloride | Meptazinol hydrochloride | Central Nervous System | 2 |
|
Meptid 100mg/1ml solution for injection ampoules
0407020L0BBABAA
|
Meptid | Meptazinol hydrochloride | Central Nervous System | 2 |
|
Modafinil 100mg/5ml oral solution
0404000R0AAADAD
|
Modafinil | Modafinil | Central Nervous System | 2 |
|
Mogadon 5mg tablets
0401010R0BDAAAC
|
Mogadon | Nitrazepam | Central Nervous System | 2 |
|
Morphine hydrochloride 10mg/5ml oral solution
0407020P0AAASAS
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | 2 |
|
Morphine hydrochloride 1mg/1ml inj ampoules
0407020P0AABBBB
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | 2 |
|
Morphine sulfate 10mg/5ml soln unit dose vials sugar free
0407020Q0AAGBGB
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 2 |
|
Mylatrip 2.5mg tablets
0407041ABBCAAAA
|
Mylatrip | Frovatriptan | Central Nervous System | 2 |
|
Nicotine 6mg medicated chewing gum sugar free
0410020B0AACCCC
|
Nicotine | Nicotine | Central Nervous System | 2 |
|
Nitrazepam 2.5mg/5ml oral suspension sugar free
0401010R0AAAQAQ
|
Nitrazepam | Nitrazepam | Central Nervous System | 2 |
|
Okedi 100mg inj pre-filled syringes
0402020AABCABAE
|
Okedi | Risperidone | Central Nervous System | 2 |
|
Ondansetron 8mg/4ml inj pre-filled syringes
0406000S0AAARAR
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Oprymea 1.57mg modified-release tablets
0409010W0BDAHAJ
|
Oprymea | Pramipexole | Central Nervous System | 2 |
|
Oprymea 2.1mg modified-release tablets
0409010W0BDAIAH
|
Oprymea | Pramipexole | Central Nervous System | 2 |
|
Oxazepam 10mg/5ml oral suspension
0401020T0AAAJAJ
|
Oxazepam | Oxazepam | Central Nervous System | 2 |
|
Paliperidone 700mg/3.5ml prolonged-release inj pf syringes
0402020ABAAAKAK
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 2 |
|
Palladone 10mg/1ml solution for injection ampoules
040702050BBAJAN
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 2 |
|
Paracetamol 1g / Phenylephrine 12.2mg oral powder sachets
0407010ABAAABAB
|
Paracetamol/phenylephrine hydrochloride | Paracetamol and phenylephrine hydrochloride | Central Nervous System | 2 |
|
Phenytoin sodium 250mg/5ml solution for injection ampoules
0408020T0AAAAAA
|
Phenytoin sodium (parent) | Phenytoin sodium | Central Nervous System | 2 |
|
Pimozide 2mg/5ml oral suspension
0402010R0AAAHAH
|
Pimozide | Pimozide | Central Nervous System | 2 |
|
Provigil 200mg tablets
0404000R0BBABAC
|
Provigil | Modafinil | Central Nervous System | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.